Calumet Statistics
Total Valuation
Calumet has a market cap or net worth of $2.80 billion. The enterprise value is $5.13 billion.
Important Dates
The next estimated earnings date is Friday, May 8, 2026, before market open.
| Earnings Date | May 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Calumet has 86.78 million shares outstanding. The number of shares has increased by 4.35% in one year.
| Current Share Class | 86.78M |
| Shares Outstanding | 86.78M |
| Shares Change (YoY) | +4.35% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 4.07% |
| Owned by Institutions (%) | 43.14% |
| Float | 56.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.68 |
| Forward PS | 0.66 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 49.43 |
| P/OCF Ratio | 25.69 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 22.58, with an EV/FCF ratio of 90.67.
| EV / Earnings | n/a |
| EV / Sales | 1.24 |
| EV / EBITDA | 22.58 |
| EV / EBIT | 64.88 |
| EV / FCF | 90.67 |
Financial Position
The company has a current ratio of 1.02
| Current Ratio | 1.02 |
| Quick Ratio | 0.43 |
| Debt / Equity | n/a |
| Debt / EBITDA | 7.39 |
| Debt / FCF | 43.45 |
| Interest Coverage | 0.37 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 1.82% |
| Return on Invested Capital (ROIC) | 4.39% |
| Return on Capital Employed (ROCE) | 4.28% |
| Weighted Average Cost of Capital (WACC) | 8.01% |
| Revenue Per Employee | $2.69M |
| Profits Per Employee | -$21,948 |
| Employee Count | 1,540 |
| Asset Turnover | 1.52 |
| Inventory Turnover | 9.67 |
Taxes
| Income Tax | -92.60M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +225.16% in the last 52 weeks. The beta is 0.85, so Calumet's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | +225.16% |
| 50-Day Moving Average | 29.47 |
| 200-Day Moving Average | 21.01 |
| Relative Strength Index (RSI) | 52.91 |
| Average Volume (20 Days) | 1,513,040 |
Short Selling Information
The latest short interest is 5.60 million, so 6.45% of the outstanding shares have been sold short.
| Short Interest | 5.60M |
| Short Previous Month | 5.42M |
| Short % of Shares Out | 6.45% |
| Short % of Float | 9.99% |
| Short Ratio (days to cover) | 3.71 |
Income Statement
In the last 12 months, Calumet had revenue of $4.14 billion and -$33.80 million in losses. Loss per share was -$0.39.
| Revenue | 4.14B |
| Gross Profit | 261.90M |
| Operating Income | 79.10M |
| Pretax Income | -126.40M |
| Net Income | -33.80M |
| EBITDA | 227.30M |
| EBIT | 79.10M |
| Loss Per Share | -$0.39 |
Full Income StatementBalance Sheet
The company has $125.10 million in cash and $2.46 billion in debt, with a net cash position of -$2.33 billion or -$26.90 per share.
| Cash & Cash Equivalents | 125.10M |
| Total Debt | 2.46B |
| Net Cash | -2.33B |
| Net Cash Per Share | -$26.90 |
| Equity (Book Value) | -487.10M |
| Book Value Per Share | -8.44 |
| Working Capital | 17.10M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $108.90 million and capital expenditures -$52.30 million, giving a free cash flow of $56.60 million.
| Operating Cash Flow | 108.90M |
| Capital Expenditures | -52.30M |
| Depreciation & Amortization | 148.20M |
| Net Borrowing | -58.70M |
| Free Cash Flow | 56.60M |
| FCF Per Share | $0.65 |
Full Cash Flow StatementMargins
Gross margin is 6.33%, with operating and profit margins of 1.91% and -0.82%.
| Gross Margin | 6.33% |
| Operating Margin | 1.91% |
| Pretax Margin | -3.06% |
| Profit Margin | -0.82% |
| EBITDA Margin | 5.49% |
| EBIT Margin | 1.91% |
| FCF Margin | 1.37% |
Dividends & Yields
Calumet does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.35% |
| Shareholder Yield | -4.35% |
| Earnings Yield | -1.21% |
| FCF Yield | 2.02% |
Dividend DetailsAnalyst Forecast
The average price target for Calumet is $28.65, which is -11.14% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | $28.65 |
| Price Target Difference | -11.14% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 7.93% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Calumet has an Altman Z-Score of 1.09 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.09 |
| Piotroski F-Score | 4 |
